← Back to Clinical Trials
Recruiting Phase 2 NCT05664841

NCT05664841 The Impact of a Virtual Magic Trick Training Program

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05664841
Status Recruiting
Phase Phase 2
Sponsor University of Alabama at Birmingham
Condition Autism
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2023-03-27
Primary Completion 2028-02-01

Eligibility & Interventions

Sex All sexes
Min Age 11 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
magic trick training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

In Phase 2, researchers evaluate early signs of effectiveness. You may be randomized to receive the active treatment or a comparator. Monitoring continues closely.

This trial targets 60 participants in total. It began in 2023-03-27 with a primary completion date of 2028-02-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The proposed project will attempt to confirm the benefits of a structured magic trick training program (MTTP) experience in adolescents with autism. Benefits of participating in a 6-week virtual MTTP will be evaluated using validated assessments to measure social-emotional competencies.

Eligibility Criteria

Inclusion Criteria: * Confirmed diagnosis (with proof of evidence) of autism; * Aged between 11 and 18 years (younger children may lack the inductive reasoning skills to learn magic tricks); * Have functional hand dexterity to do magic tricks * Intact cognition as indicated by a score above the corresponding cut-off point of the child's age on the Mini-Mental Examination for Children; and * Access to internet and a computer or smartphone that can perform videoconferencing. Exclusion Criteria: * Severe hearing or visual impairments that prevent online learning; * Previous participation in organized magic learning program or camp; * Current or planned participation in psychological therapy or a clinical trial during the study period that could affect the outcomes of the study.

Contact & Investigator

Central Contact

Hon Yuen

✉ yuen@uab.edu

📞 205-934-6301

Principal Investigator

Hon Yuen, PhD

PRINCIPAL INVESTIGATOR

University of Alabama at Birmingham

Frequently Asked Questions

Who can join the NCT05664841 clinical trial?

This trial is open to participants of all sexes, aged 11 Years or older, up to 18 Years, studying Autism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

What phase is the NCT05664841 trial and what does that mean for participants?

Phase 2 trials evaluate whether the treatment shows signs of effectiveness while continuing to monitor safety. More participants are enrolled than in Phase 1 to help refine the treatment protocol.

Is NCT05664841 currently recruiting?

Yes, NCT05664841 is actively recruiting participants. Contact the research team at yuen@uab.edu for enrollment information.

Where is the NCT05664841 trial being conducted?

This trial is being conducted at Birmingham, United States.

Who is sponsoring the NCT05664841 clinical trial?

NCT05664841 is sponsored by University of Alabama at Birmingham. The principal investigator is Hon Yuen, PhD at University of Alabama at Birmingham. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology